Cargando…

Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma

INTRODUCTION: Checkpoint inhibitors have significantly improved the prognosis of patients with advanced melanoma. These cancer immunotherapy drugs have specific endocrine autoimmune toxicity. We describe a case of an adrenal insufficiency secondary to pembrolizumab, an anti-programmed cell death-1 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paepegaey, Anne-Cécile, Lheure, Coralie, Ratour, Carole, Lethielleux, Gaëlle, Clerc, Jérome, Bertherat, Jérome, Kramkimel, Nora, Groussin, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686573/ https://www.ncbi.nlm.nih.gov/pubmed/29264517 http://dx.doi.org/10.1210/js.2017-00170

Ejemplares similares

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer
por: Huillard, Olivier, et al.
Publicado: (2017)

MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data
por: Schubert, Louis, et al.
Publicado: (2023)

Checkpoint Inhibitor in a Melanoma Patient With Polyendocrinopathy and Gangrenous Gallbladder With a Mass
por: Fernandes, Nayson L, et al.
Publicado: (2020)

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
por: Ferré, Elise M. N., et al.
Publicado: (2021)

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B–Secreting Adrenocortical Carcinoma
por: Espiard, Stéphanie, et al.
Publicado: (2017)

Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
por: Balakirouchenane, David, et al.
Publicado: (2020)

Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma
por: Bricaire, Léopoldine, et al.
Publicado: (2017)

MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer
por: Garcia, Cyril, et al.
Publicado: (2019)

NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK
por: Cormier, Françoise, et al.
Publicado: (2023)

Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity
Publicado: (1981)

Autoimmune polyendocrinopathy and hypophysitis after Puumala hantavirus infection
por: Tarvainen, Marlene, et al.
Publicado: (2016)

Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Meager, Anthony, et al.
Publicado: (2006)

Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study
por: Zulfiqar, AA, et al.
Publicado: (2017)

Autoimmune thyroiditis - track towards autoimmune polyendocrinopathy type III
por: Hodé, Annelie Kérékou, et al.
Publicado: (2021)

Immune Check Point Inhibitors Triggering Non Autoimmune Polyendocrinopathy
por: Vergne-Santiago, Norma, et al.
Publicado: (2021)

Preoperative Detection of Liver Involvement by Right-Sided Adrenocortical Carcinoma Using CT and MRI
por: Kedra, Alice, et al.
Publicado: (2021)

Anti-Interferon Auto-Antibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
por: Levin, Michael
Publicado: (2006)

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy: Insights into Genotype-Phenotype Correlation
por: Capalbo, Donatella, et al.
Publicado: (2012)

Pathogenic and Protective Autoantibodies in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
por: Kashem, Sakeen W., et al.
Publicado: (2017)

Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients
por: Schmitt, Monica M., et al.
Publicado: (2021)

Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report
por: Kuint, R., et al.
Publicado: (2017)

Malignant melanoma treated with pembrolizumab during pregnancy: A case report and review of the literature
por: Anami, Yuki, et al.
Publicado: (2021)

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
por: Buffet, Camille, et al.
Publicado: (2017)

Spotlight on pembrolizumab in the treatment of advanced melanoma
por: Rajakulendran, Thanashan, et al.
Publicado: (2015)

Reversible adrenal insufficiency and heterophile antibodies in a case of autoimmune polyendocrinopathy syndrome
por: Kharb, Sandeep, et al.
Publicado: (2013)

Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome
por: Gutierrez, Maria J., et al.
Publicado: (2017)

Exercises de statistique et probabilités
por: Lethielleux, Maurice
Publicado: (2009)

Debilitating Skin Toxicity Associated with Pembrolizumab Therapy in an 81-Year-Old Female with Malignant Melanoma
por: Khokhar, Muhammad O., et al.
Publicado: (2016)

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
por: Barnhart, Carrie
Publicado: (2015)

Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma
por: Dollin, Yonatan, et al.
Publicado: (2020)

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity
por: Barzaghi, Federica, et al.
Publicado: (2012)

Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea
por: Zama, Daniele, et al.
Publicado: (2014)

Gene/Cell Therapy Approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
por: Passerini, Laura, et al.
Publicado: (2014)

Carney complex (CNC)
por: Bertherat, Jérôme
Publicado: (2006)

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome
por: Besnard, Marine, et al.
Publicado: (2022)

A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report
por: O’Gorman, Clodagh S, et al.
Publicado: (2013)

Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked
por: Rosenberg, Jacob M., et al.
Publicado: (2018)

Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy in Two Siblings: Same Mutations but Very Different Phenotypes
por: Carpino, Andrea, et al.
Publicado: (2021)

Long-term Outcome of Kidney Transplantation in 6 Patients With Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy
por: Laakso, Saila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dnorachskqfn334eb7c9nf7qa2